| 2022-TAYL-69671 | |
| Researchers at Purdue University have developed polymer salts with high rates of dissolution that improve drug release, particularly for lipophilic drugs, that can account for approximately 90% of developmental or approved drugs . Typically, protonated polymers have been used as enteric coatings to prevent drug release in the stomach. These polymers developed for use as enteric coatings have been used in the formulation of amorphous solid dispersions (ASD), where the drug is molecularly dispersed in a polymer matrix. However, only low amounts of the drugs can be blended with the polymers due to their low rates of dissolution upon reaching their target. The Purdue researchers found that ionizing an enteric polymer into a polymer salt had a higher rate of dissolution in the drug's target area and improved the drug release from ASDs until after the formulation exited the stomach. These polymer salts also have improved solubility in organic solvents, allowing easier processing. Technology Validation: The drug release profile of an enteric non-ionized polymer was compared with an ionized polymer salt, and it was observed that the rate of drug dissolution and release for the ionized polymer salt was twice that of the non-ionized polymer. Related Publication: Qingqing Qi, Lynne S. Taylor. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation. International Journal of Pharmaceutics. Volume 622, 2022, 121886, ISSN 0378-5173. https://doi.org/10.1016/j.ijpharm.2022.121886. Advantages - Allows for higher drug loading - Soluble in organic solvents - Higher drug release performance Applications - Pharmaceuticals manufacturing |
|
|
|
|
Jan 18, 2023
PCT-Gov. Funding
WO
(None)
(None)
Aug 18, 2022
Provisional-Gov. Funding
United States
(None)
(None)
Feb 14, 2022
Provisional-Gov. Funding
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |
